Opioid Str federal funding in FY2024
USAspending.gov records $6,537,610,680.35 in Opioid Str (CFDA 93.788) obligations for fiscal year 2024. That yearlyTrend cell is 99.5% of this program’s published obligation total of $6,571,889,598.81. The year-side award-record count on the pair is 371; the program extract lists 377 awards across years. This page is the program-and-year join: Opioid Str crossed with federal FY2024 — not every federal dollar in FY2024, not the program’s $6,571,889,598.81 extract-wide book, and not an overdose dashboard, a treatment-bed census, or a state SSA roster. USAspending.gov is the source. Correlation is not causation. Obligations are not outlays.
Key figures
- Opioid Str FY2024: $6,537,610,680.35 in USAspending obligations (CFDA 93.788).
- FY2024 is about 99.5% of the program all-year obligation total of $6,571,889,598.81.
- The pair lists 371 FY2024 award records; the program extract lists 377 awards across years.
- The join is Opioid Str × FY2024, not other SAMHSA block grants, a Medicaid SUD spend, or a named-provider list.
- Figures are obligations, not outlays.
Opioid STR overlapping FY2024 — CFDA 93.788
CFDA 93.788 and fiscal year 2024 share one yearlyTrend cell. $6,537,610,680.35 is the USAspending.gov obligation sum on the row that carries both tags. It is not Opioid Str’s nationwide all-year total of $6,571,889,598.81, not every federal dollar coded to FY2024, and not a provider directory, a bed census, or an outlay register. 371 is the FY2024 award-record count on this pair; 377 is the program-extract action count. Modifications and repeat awards add rows. Unique recipients are unpublished.
Read /programs/93.788/ (CFDA 93.788) for the program rollup, /fiscal-years/2024/ (FY2024 federal spending) for the year rollup, /programs/ (All programs) for every CFDA hub, and /ties/ (All spending ties) for the rest of the join list. Do not add those pages into $6,537,610,680.35. Recipients are unpublished. Three hundred seventy-one FY2024 awards is not 371 unique providers. State instruments and modifications add rows.
Opioid Str as the program side
USAspending labels CFDA 93.788 as Opioid Str. That code produced $6,537,610,680.35 when crossed with fiscal year 2024. The program-wide hub does not require a FY2024 filter. The year hub does not require this CFDA. Only this tie applies both filters. The CFDA title is OPIOID STR. This packet does not expand the STR acronym into a workplan, nor split prevention, treatment, or recovery lines inside the year cell. FY2024 figures can still move after deobligations or recoveries.
The program extract-wide obligation total is $6,571,889,598.81 across 377 award records. FY2024 is 99.5% of that book. Other fiscal-year rows for CFDA 93.788 are separate cells. Do not fold /programs/ into this join as if every CFDA were this one. Keep 93.788.
FY2024 Opioid STR obligations are not treatment episodes
FY2024 on USAspending.gov is a federal fiscal year, not a calendar year and not a state fiscal year. $6,537,610,680.35 is the Opioid Str slice of that year in this extract, not the government-wide FY2024 total. FY2024 figures can still move after deobligations or recoveries. Prefer /fiscal-years/2024/ if the live year table moved. Outlays are unpublished.
An obligation is a legal commitment recorded on an award. An outlay is a payment from the Treasury. $6,537,610,680.35 is the former for Opioid STR in FY2024. Later deobligations, recoveries, or payment schedules can change what leaves the Treasury without this join rewriting itself into a cash register. This page reports $6,537,610,680.35 as given.
371 FY2024 awards are not 371 treatment programs
371 is the FY2024 award-record count published on this pair. 377 is the program-extract award-record count across years. Dividing $6,537,610,680.35 by 377 would mix a one-year dollar total with a multi-year row count, so this page does not publish that ratio as a typical award. Unique recipients are unpublished. Three hundred seventy-one FY2024 awards is not 371 unique providers. State instruments and modifications add rows.
State rankings this join cannot support
Budget justifications, program evaluation reports, and press releases answer other questions. They are not the source of this cell. If a chart mixes other SAMHSA block grants, a Medicaid SUD spend, or a named-provider list with CFDA 93.788 in FY2024, the chart has left this join. State agencies, providers, and patient counts are unpublished on this packet.
Hubs for CFDA 93.788 × FY2024
Open CFDA 93.788 for the program rollup, FY2024 federal spending for the fiscal-year rollup, All programs for other CFDA hubs, and All spending ties for other pairs. None of those links convert this cell into other SAMHSA block grants, a Medicaid SUD spend, or a named-provider list, into outlays this packet omits, or into a contractor list. Cite both sides: Opioid Str and FY2024, $6,537,610,680.35, USAspending.gov, obligations only. CFDA 93.788 remains the program key.
Questions
- How much did Opioid Str show in federal obligations in FY2024?
- USAspending.gov records $6,537,610,680.35 in Opioid Str obligations for FY2024 (CFDA 93.788). That is an obligation aggregate for the program-year pair, not an outlay and not the government-wide FY2024 total. Original filings remain on USAspending.gov.
- Is Opioid STR FY2024 cash already spent on treatment?
- No. $6,537,610,680.35 is a yearlyTrend obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for Opioid Str in FY2024. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.
- Do 371 awards mean 371 treatment programs?
- No. 371 is the FY2024 award-record count on this pair, not a published unique-recipient census. The program extract lists 377 awards across years. Modifications can add rows. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.
- Which pages parent Opioid Str FY2024?
- The CFDA 93.788 hub is the program parent. The FY2024 federal-spending hub is the year parent. All programs lists CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Opioid Str × FY2024 at $6,537,610,680.35.
USAspending.gov CFDA program yearlyTrend by fiscal year. Obligations are not outlays.